Emodin induces apoptosis of concanavalin A-stimulated murine splenocytes

被引:5
作者
An, Subin [1 ]
Bing, So Jin [1 ]
Cho, Jinhee [1 ]
Herath, Kalahe Hewage Iresha Nadeeka Madushani [1 ,2 ]
Kim, Areum [1 ,2 ]
Chang, Hyeun Wook [3 ]
Jee, Youngheun [1 ,2 ,4 ]
机构
[1] Jeju Natl Univ, Coll Vet Med, Jeju 63243, South Korea
[2] Jeju Natl Univ, Interdisciplinary Grad Program Adv Convergence Te, Jeju 63243, South Korea
[3] Yeungnam Univ, Coll Pharm, Gyongsan 38541, Gyeongbuk, South Korea
[4] Jeju Natl Univ, Vet Med Res Inst, Jeju 63243, South Korea
关键词
emodin; apoptosis; autoimmune disease; concanavalin A; immune cells; T-CELL APOPTOSIS; NF-KAPPA-B; DENDRITIC CELLS; CANCER CELLS; LYMPHOCYTES; ACTIVATION; MECHANISM; KINASE; PROLIFERATION;
D O I
10.1007/s10068-016-0260-y
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Emodin, one of the major compounds in the herb Reynoutria elliptica, is known to maintain immunosuppressive, anti-allergic, anti-cancer, and anti-inflammatory effects. In this study, we assessed the possibility of using emodin to induce apoptosis in stimulated immune cells in vitro. After treatment with emodin and concanavalin A (Con A), we observed DNA damage-induced apoptosis in splenocytes. Moreover, treatment with emodin and Con A increased the number of apoptotic splenocytes compared with untreated controls. Emodin also diminished the size of CD45R/B220(+) cells, CD19(+)CD69(+) cells, and cDC populations. These results indicate that emodin-induced apoptosis was involved in attenuating the immune activity promoted by DNA damage and in decreasing the number of CD45R/B220(+) B cells and CD19(+)CD69(+) activating B cells. This demonstration of emodin inducing apoptosis of Con A-stimulated immune cells indicates its potential utility as a therapy for diseases caused by abnormally activated immune cells.
引用
收藏
页码:1693 / 1700
页数:8
相关论文
共 21 条
[11]   Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation [J].
Lu, Yue ;
Yang, Ju Hye ;
Li, Xian ;
Hwangbo, Kyoung ;
Hwang, Seung-Lark ;
Taketomi, Yoshitaka ;
Murakami, Makoto ;
Chang, Young-Chae ;
Kim, Cheorl-Ho ;
Son, Jong-Keun ;
Chang, Hyeun Wook .
BIOCHEMICAL PHARMACOLOGY, 2011, 82 (11) :1700-1708
[12]   Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-κB activation by disrupting lipid rafts in CD14-negative endothelial cells [J].
Meng, Guoquan ;
Liu, Yiyao ;
Lou, Changchun ;
Yang, Hong .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) :1628-1644
[13]   Apoptosis in the development and maintenance of the immune system [J].
Opferman, JT ;
Korsmeyer, SJ .
NATURE IMMUNOLOGY, 2003, 4 (05) :410-415
[14]   Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance [J].
Pender, MP .
IMMUNOLOGY AND CELL BIOLOGY, 1999, 77 (03) :216-223
[15]   Emodin induces human T cell apoptosis in vitro by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction [J].
Qu, Kai ;
Shen, Nai-ying ;
Xu, Xin-sen ;
Su, Hai-bo ;
Wei, Ji-chao ;
Tai, Ming-hui ;
Meng, Fan-di ;
Zhou, Lei ;
Zhang, Yue-lang ;
Liu, Chang .
ACTA PHARMACOLOGICA SINICA, 2013, 34 (09) :1217-1228
[16]  
SCHMIED M, 1993, AM J PATHOL, V143, P446
[17]   Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent [J].
Srinivas, Gopal ;
Babykutty, Suboj ;
Satbiadevan, Priya Prasanna ;
Srinivas, Priya .
MEDICINAL RESEARCH REVIEWS, 2007, 27 (05) :591-608
[18]   Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation [J].
Thien-Phong Vu Manh ;
Alexandre, Yannick ;
Baranek, Thomas ;
Crozat, Karine ;
Dalod, Marc .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (07) :1706-1715
[19]   Emodin Prolongs Recipient Survival Time After Orthotopic Liver Transplantation in Rats by Polarizing the Th1/Th2 Paradigm to Th2 [J].
Tong, Hongfei ;
Chen, Kangjie ;
Chen, Hui ;
Wu, Huayong ;
Lin, Haiduo ;
Ni, Zhonglin ;
Lin, Shengzhang .
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2011, 294 (03) :445-452
[20]  
ZHANG LS, 1995, CANCER RES, V55, P3890